<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">35464473</PMID><DateCompleted><Year>2022</Year><Month>04</Month><Day>26</Day></DateCompleted><DateRevised><Year>2022</Year><Month>12</Month><Day>07</Day></DateRevised><Article PubModel="Electronic-eCollection"><Journal><ISSN IssnType="Electronic">1664-3224</ISSN><JournalIssue CitedMedium="Internet"><Volume>13</Volume><PubDate><Year>2022</Year></PubDate></JournalIssue><Title>Frontiers in immunology</Title><ISOAbbreviation>Front Immunol</ISOAbbreviation></Journal><ArticleTitle>Persistent Lung Injury and Prothrombotic State in Long COVID.</ArticleTitle><Pagination><StartPage>862522</StartPage><MedlinePgn>862522</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">862522</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.3389/fimmu.2022.862522</ELocationID><Abstract><AbstractText>Lung injury may persist during the recovery period of COVID-19 as shown through imaging, six-minute walk, and lung function tests. The pathophysiological mechanisms leading to long COVID have not been adequately explained. Our aim is to investigate the basis of pulmonary susceptibility during sequelae and the possibility that prothrombotic states may influence long-term pulmonary symptoms of COVID-19. The patient's lungs remain vulnerable during the recovery stage due to persistent shedding of the virus, the inflammatory environment, the prothrombotic state, and injury and subsequent repair of the blood-air barrier. The transformation of inflammation to proliferation and fibrosis, hypoxia-involved vascular remodeling, vascular endothelial cell damage, phosphatidylserine-involved hypercoagulability, and continuous changes in serological markers all contribute to post-discharge lung injury. Considering the important role of microthrombus and arteriovenous thrombus in the process of pulmonary functional lesions to organic lesions, we further study the possibility that prothrombotic states, including pulmonary vascular endothelial cell activation and hypercoagulability, may affect long-term pulmonary symptoms in long COVID. Early use of combined anticoagulant and antiplatelet therapy is a promising approach to reduce the incidence of pulmonary sequelae. Essentially, early treatment can block the occurrence of thrombotic events. Because impeded pulmonary circulation causes large pressure imbalances over the alveolar membrane leading to the infiltration of plasma into the alveolar cavity, inhibition of thrombotic events can prevent pulmonary hypertension, formation of lung hyaline membranes, and lung consolidation.</AbstractText><CopyrightInformation>Copyright &#xa9; 2022 Xiang, Jing, Wang, Novakovic and Shi.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Xiang</LastName><ForeName>Mengqi</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Hematology, First Affiliated Hospital of Harbin Medical University, Harbin Medical University, Harbin, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Jing</LastName><ForeName>Haijiao</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>Department of Hematology, First Affiliated Hospital of Harbin Medical University, Harbin Medical University, Harbin, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wang</LastName><ForeName>Chengyue</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Department of Hematology, First Affiliated Hospital of Harbin Medical University, Harbin Medical University, Harbin, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Novakovic</LastName><ForeName>Valerie A</ForeName><Initials>VA</Initials><AffiliationInfo><Affiliation>Department of Research, Veterans Affairs Boston Healthcare System, Harvard Medical School, Boston, MA, United States.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Shi</LastName><ForeName>Jialan</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Department of Hematology, First Affiliated Hospital of Harbin Medical University, Harbin Medical University, Harbin, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Research, Veterans Affairs Boston Healthcare System, Harvard Medical School, Boston, MA, United States.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA, United States.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016454">Review</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2022</Year><Month>04</Month><Day>07</Day></ArticleDate></Article><MedlineJournalInfo><Country>Switzerland</Country><MedlineTA>Front Immunol</MedlineTA><NlmUniqueID>101560960</NlmUniqueID><ISSNLinking>1664-3224</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000359" MajorTopicYN="N">Aftercare</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000086382" MajorTopicYN="Y">COVID-19</DescriptorName><QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D055370" MajorTopicYN="Y">Lung Injury</DescriptorName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D010351" MajorTopicYN="N">Patient Discharge</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000086402" MajorTopicYN="N">SARS-CoV-2</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D019851" MajorTopicYN="Y">Thrombophilia</DescriptorName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D013927" MajorTopicYN="Y">Thrombosis</DescriptorName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000094024" MajorTopicYN="N">Post-Acute COVID-19 Syndrome</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">COVID-19</Keyword><Keyword MajorTopicYN="N">anticoagulation</Keyword><Keyword MajorTopicYN="N">long COVID</Keyword><Keyword MajorTopicYN="N">phosphatidylserine</Keyword><Keyword MajorTopicYN="N">therapy</Keyword><Keyword MajorTopicYN="N">thrombosis</Keyword></KeywordList><CoiStatement>The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2022</Year><Month>1</Month><Day>26</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2022</Year><Month>3</Month><Day>17</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2022</Year><Month>4</Month><Day>25</Day><Hour>5</Hour><Minute>33</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2022</Year><Month>4</Month><Day>26</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2022</Year><Month>4</Month><Day>27</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2022</Year><Month>4</Month><Day>7</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">35464473</ArticleId><ArticleId IdType="pmc">PMC9021447</ArticleId><ArticleId IdType="doi">10.3389/fimmu.2022.862522</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Rello J, Storti E, Belliato M, Serrano R. Clinical Phenotypes of SARS-CoV-2: Implications for Clinicians and Researchers. Eur Respir J (2020) 55(5):2001028. doi:&#xa0;10.1183/13993003.01028-2020</Citation><ArticleIdList><ArticleId IdType="doi">10.1183/13993003.01028-2020</ArticleId><ArticleId IdType="pmc">PMC7236837</ArticleId><ArticleId IdType="pubmed">32341111</ArticleId></ArticleIdList></Reference><Reference><Citation>Attaway AH, Scheraga RG, Bhimraj A, Biehl M, Hatipo&#x11f;lu U. Severe COVID-19 Pneumonia: Pathogenesis and Clinical Management. BMJ (2021) 372:n436. doi:&#xa0;10.1136/bmj.n436</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmj.n436</ArticleId><ArticleId IdType="pubmed">33692022</ArticleId></ArticleIdList></Reference><Reference><Citation>Oronsky B, Larson C, Hammond TC, Oronsky A, Kesari S, Lybeck M, et al. . A Review of Persistent Post-COVID Syndrome (PPCS). Clin Rev Allergy Immunol (2021) 20:1&#x2013;9. doi:&#xa0;10.1007/s12016-021-08848-3</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s12016-021-08848-3</ArticleId><ArticleId IdType="pmc">PMC7896544</ArticleId><ArticleId IdType="pubmed">33609255</ArticleId></ArticleIdList></Reference><Reference><Citation>Cueto-Robledo G, Porres-Aguilar M, Puebla-Aldama D, Barrag&#xe1;n-Mart&#xed;nez MDP, Jurado-Hern&#xe1;ndez MY, Garc&#xed;a-C&#xe9;sar M, et al. . Severe Pulmonary Hypertension: An Important Sequel After Severe Post-Acute COVID-19 Pneumonia. Curr Probl Cardiol (2021) 30:101004. doi:&#xa0;10.1016/j.cpcardiol.2021.101004</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cpcardiol.2021.101004</ArticleId><ArticleId IdType="pmc">PMC8482545</ArticleId><ArticleId IdType="pubmed">34601005</ArticleId></ArticleIdList></Reference><Reference><Citation>Michalski JE, Kurche JS, Schwartz DA. From ARDS to Pulmonary Fibrosis: The Next Phase of the COVID-19 Pandemic? Transl Res (2022) 241:13&#x2013;24. doi:&#xa0;10.1016/j.trsl.2021.09.001</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.trsl.2021.09.001</ArticleId><ArticleId IdType="pmc">PMC8452088</ArticleId><ArticleId IdType="pubmed">34547499</ArticleId></ArticleIdList></Reference><Reference><Citation>Archer SL, Sharp WW, Weir EK. Differentiating COVID-19 Pneumonia From Acute Respiratory Distress Syndrome and High Altitude Pulmonary Edema: Therapeutic Implications. Circulation (2020) 142(2):101&#x2013;4. doi:&#xa0;10.1161/CIRCULATIONAHA.120.047915</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/CIRCULATIONAHA.120.047915</ArticleId><ArticleId IdType="pmc">PMC7363563</ArticleId><ArticleId IdType="pubmed">32369390</ArticleId></ArticleIdList></Reference><Reference><Citation>John AE, Joseph C, Jenkins G, Tatler AL. COVID-19 and Pulmonary Fibrosis: A Potential Role for Lung Epithelial Cells and Fibroblasts. Immunol Rev (2021) 302(1):228&#x2013;40. doi:&#xa0;10.1111/imr.12977</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/imr.12977</ArticleId><ArticleId IdType="pmc">PMC8237078</ArticleId><ArticleId IdType="pubmed">34028807</ArticleId></ArticleIdList></Reference><Reference><Citation>Fox SE, Akmatbekov A, Harbert JL, Li G, Quincy Brown J, Vander Heide RS. Pulmonary and Cardiac Pathology in African American Patients With COVID-19: An Autopsy Series From New Orleans. Lancet Respir Med (2020) 8(7):681&#x2013;6. doi:&#xa0;10.1016/S2213-2600(20)30243-5</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S2213-2600(20)30243-5</ArticleId><ArticleId IdType="pmc">PMC7255143</ArticleId><ArticleId IdType="pubmed">32473124</ArticleId></ArticleIdList></Reference><Reference><Citation>Blanco JR, Cobos-Ceballos MJ, Navarro F, Sanjoaquin I, Arnaiz de Las Revillas F, Bernal E, et al. . Pulmonary Long-Term Consequences of COVID-19 Infections After Hospital Discharge. Clin Microbiol Infect (2021) 27(6):892&#x2013;6. doi:&#xa0;10.1016/j.cmi.2021.02.019</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cmi.2021.02.019</ArticleId><ArticleId IdType="pmc">PMC7920814</ArticleId><ArticleId IdType="pubmed">33662544</ArticleId></ArticleIdList></Reference><Reference><Citation>Higgins V, Sohaei D, Diamandis EP, Prassas I. COVID-19: From an Acute to Chronic Disease? Potential Long-Term Health Consequences. Crit Rev Clin Lab Sci (2021) 58(5):297&#x2013;310. doi:&#xa0;10.1080/10408363.2020.1860895</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/10408363.2020.1860895</ArticleId><ArticleId IdType="pubmed">33347790</ArticleId></ArticleIdList></Reference><Reference><Citation>Huang L, Yao Q, Gu X, Wang Q, Ren L, Wang Y, et al. . 1-Year Outcomes in Hospital Survivors With COVID-19: A Longitudinal Cohort Study. Lancet (2021) 398(10302):747&#x2013;58. doi:&#xa0;10.1016/S0140-6736(21)01755-4</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(21)01755-4</ArticleId><ArticleId IdType="pmc">PMC8389999</ArticleId><ArticleId IdType="pubmed">34454673</ArticleId></ArticleIdList></Reference><Reference><Citation>Huang C, Huang L, Wang Y, Li X, Ren L, Gu X, et al. . 6-Month Consequences of COVID-19 in Patients Discharged From Hospital: A Cohort Study. Lancet (2021) 397(10270):220&#x2013;32. doi:&#xa0;10.1016/S0140-6736(20)32656-8</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(20)32656-8</ArticleId><ArticleId IdType="pmc">PMC7833295</ArticleId><ArticleId IdType="pubmed">33428867</ArticleId></ArticleIdList></Reference><Reference><Citation>Olliaro PL. An Integrated Understanding of Long-Term Sequelae After Acute COVID-19. Lancet Respir Med (2021) 9(7):679&#x2013;80. doi:&#xa0;10.1016/S2213-2600(21)00206-X</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S2213-2600(21)00206-X</ArticleId><ArticleId IdType="pmc">PMC8099314</ArticleId><ArticleId IdType="pubmed">33964246</ArticleId></ArticleIdList></Reference><Reference><Citation>Adeloye D, Elneima O, Daines L, Poinasamy K, Quint JK, Walker S, et al. . The Long-Term Sequelae of COVID-19: An International Consensus on Research Priorities for Patients With Pre-Existing and New-Onset Airways Disease. Lancet Respir Med (2021) 9(12):1467&#x2013;78. doi:&#xa0;10.1016/S2213-2600(21)00286-1</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S2213-2600(21)00286-1</ArticleId><ArticleId IdType="pmc">PMC8372501</ArticleId><ArticleId IdType="pubmed">34416191</ArticleId></ArticleIdList></Reference><Reference><Citation>Naeije R, Caravita S. Phenotyping Long COVID. Eur Respir J (2021) 58(2):2101763. doi:&#xa0;10.1183/13993003.01763-2021</Citation><ArticleIdList><ArticleId IdType="doi">10.1183/13993003.01763-2021</ArticleId><ArticleId IdType="pmc">PMC8287735</ArticleId><ArticleId IdType="pubmed">34244323</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang YY, Li BR, Ning BT. The Comparative Immunological Characteristics of SARS-CoV, MERS-CoV, and SARS-CoV-2 Coronavirus Infections. Front Immunol (2020) 11:2033. doi:&#xa0;10.3389/fimmu.2020.02033</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2020.02033</ArticleId><ArticleId IdType="pmc">PMC7457039</ArticleId><ArticleId IdType="pubmed">32922406</ArticleId></ArticleIdList></Reference><Reference><Citation>Peng Y, Tao H, Satyanarayanan SK, Jin K, Su H. A Comprehensive Summary of the Knowledge on COVID-19 Treatment. Aging Dis (2021) 12(1):155&#x2013;91. doi:&#xa0;10.14336/AD.2020.1124</Citation><ArticleIdList><ArticleId IdType="doi">10.14336/AD.2020.1124</ArticleId><ArticleId IdType="pmc">PMC7801274</ArticleId><ArticleId IdType="pubmed">33532135</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen W, Lan Y, Yuan X, Deng X, Li Y, Cai X, et al. . Detectable 2019-Ncov Viral RNA in Blood Is a Strong Indicator for the Further Clinical Severity. Emerg Microbes Infect (2020) 9(1):469&#x2013;73. doi:&#xa0;10.1080/22221751.2020.1732837</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/22221751.2020.1732837</ArticleId><ArticleId IdType="pmc">PMC7054964</ArticleId><ArticleId IdType="pubmed">32102625</ArticleId></ArticleIdList></Reference><Reference><Citation>Pinney SP, Giustino G, Halperin JL, Mechanick JI, Neibart E, Olin JW, et al. . Coronavirus Historical Perspective, Disease Mechanisms, and Clinical Outcomes: JACC Focus Seminar. J Am Coll Cardiol (2020) 76(17):1999&#x2013;2010. doi:&#xa0;10.1016/j.jacc.2020.08.058</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jacc.2020.08.058</ArticleId><ArticleId IdType="pmc">PMC7571970</ArticleId><ArticleId IdType="pubmed">33092736</ArticleId></ArticleIdList></Reference><Reference><Citation>Sa Ribero M, Jouvenet N, Dreux M, Nisole S. Interplay Between SARS-CoV-2 and the Type I Interferon Response. PloS Pathog (2020) 16(7):e1008737. doi:&#xa0;10.1371/journal.ppat.1008737</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.ppat.1008737</ArticleId><ArticleId IdType="pmc">PMC7390284</ArticleId><ArticleId IdType="pubmed">32726355</ArticleId></ArticleIdList></Reference><Reference><Citation>Maiuolo J, Mollace R, Gliozzi M, Musolino V, Carresi C, Paone S, et al. . The Contribution of Endothelial Dysfunction in Systemic Injury Subsequent to SARS-CoV-2 Infection. Int J Mol Sci (2020) 21(23):9309. doi:&#xa0;10.3390/ijms21239309</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijms21239309</ArticleId><ArticleId IdType="pmc">PMC7730352</ArticleId><ArticleId IdType="pubmed">33291346</ArticleId></ArticleIdList></Reference><Reference><Citation>Godoy LC, Goligher EC, Lawler PR, Slutsky AS, Zarychanski R. Anticipating and Managing Coagulopathy and Thrombotic Manifestations of Severe COVID-19. CMAJ (2020) 192(40):E1156&#x2013;61. doi:&#xa0;10.1503/cmaj.201240</Citation><ArticleIdList><ArticleId IdType="doi">10.1503/cmaj.201240</ArticleId><ArticleId IdType="pmc">PMC7546749</ArticleId><ArticleId IdType="pubmed">32816822</ArticleId></ArticleIdList></Reference><Reference><Citation>McElvaney OJ, McEvoy NL, McElvaney OF, Carroll TP, Murphy MP, Dunlea DM, et al. . Characterization of the Inflammatory Response to Severe COVID-19 Illness. Am J Respir Crit Care Med (2020) 202(6):812&#x2013;21. doi:&#xa0;10.1164/rccm.202005-1583OC</Citation><ArticleIdList><ArticleId IdType="doi">10.1164/rccm.202005-1583OC</ArticleId><ArticleId IdType="pmc">PMC7491404</ArticleId><ArticleId IdType="pubmed">32584597</ArticleId></ArticleIdList></Reference><Reference><Citation>Noubouossie DF, Reeves BN, Strahl BD, Key NS. Neutrophils: Back in the Thrombosis Spotlight. Blood (2019) 133(20):2186&#x2013;97. doi:&#xa0;10.1182/blood-2018-10-862243</Citation><ArticleIdList><ArticleId IdType="doi">10.1182/blood-2018-10-862243</ArticleId><ArticleId IdType="pmc">PMC7218731</ArticleId><ArticleId IdType="pubmed">30898858</ArticleId></ArticleIdList></Reference><Reference><Citation>Mackman N, Antoniak S, Wolberg AS, Kasthuri R, Key NS. Coagulation Abnormalities and Thrombosis in Patients Infected With SARS-CoV-2 and Other Pandemic Viruses. Arterioscler Thromb Vasc Biol (2020) 40(9):2033&#x2013;44. doi:&#xa0;10.1161/ATVBAHA.120.314514</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/ATVBAHA.120.314514</ArticleId><ArticleId IdType="pmc">PMC7447001</ArticleId><ArticleId IdType="pubmed">32657623</ArticleId></ArticleIdList></Reference><Reference><Citation>Bhatia P, Mohammed S. Severe Hypoxemia in Early COVID-19 Pneumonia. Am J Respir Crit Care Med (2020) 202(4):621&#x2013;2. doi:&#xa0;10.1164/rccm.202004-1313LE</Citation><ArticleIdList><ArticleId IdType="doi">10.1164/rccm.202004-1313LE</ArticleId><ArticleId IdType="pmc">PMC7427389</ArticleId><ArticleId IdType="pubmed">32579023</ArticleId></ArticleIdList></Reference><Reference><Citation>Piazza G, Morrow DA. Diagnosis, Management, and Pathophysiology of Arterial and Venous Thrombosis in COVID-19. JAMA (2020) 324(24):2548&#x2013;9. doi:&#xa0;10.1001/jama.2020.23422</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jama.2020.23422</ArticleId><ArticleId IdType="pubmed">33226423</ArticleId></ArticleIdList></Reference><Reference><Citation>Price LC, McCabe C, Garfield B, Wort SJ. Thrombosis and COVID-19 Pneumonia: The Clot Thickens! Eur Respir J (2020) 56(1):2001608. doi:&#xa0;10.1183/13993003.01608-2020</Citation><ArticleIdList><ArticleId IdType="doi">10.1183/13993003.01608-2020</ArticleId><ArticleId IdType="pmc">PMC7301830</ArticleId><ArticleId IdType="pubmed">32554532</ArticleId></ArticleIdList></Reference><Reference><Citation>Silva Andrade B, Siqueira S, de Assis Soares WR, de Souza Rangel F, Santos NO, Dos Santos Freitas A, et al. . Long-COVID and Post-COVID Health Complications: An Up-To-Date Review on Clinical Conditions and Their Possible Molecular Mechanisms. Viruses (2021) 13(4):700. doi:&#xa0;10.3390/v13040700</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/v13040700</ArticleId><ArticleId IdType="pmc">PMC8072585</ArticleId><ArticleId IdType="pubmed">33919537</ArticleId></ArticleIdList></Reference><Reference><Citation>Pretorius E, Vlok M, Venter C, Bezuidenhout JA, Laubscher GJ, Steenkamp J, et al. . Persistent Clotting Protein Pathology in Long COVID/Post-Acute Sequelae of COVID-19 (PASC) Is Accompanied by Increased Levels of Antiplasmin. Cardiovasc Diabetol (2021) 20(1):172. doi:&#xa0;10.1186/s12933-021-01359-7</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12933-021-01359-7</ArticleId><ArticleId IdType="pmc">PMC8381139</ArticleId><ArticleId IdType="pubmed">34425843</ArticleId></ArticleIdList></Reference><Reference><Citation>Fogarty H, Townsend L, Morrin H, Ahmad A, Comerford C, Karampini E, et al. . Persistent Endotheliopathy in the Pathogenesis of Long COVID Syndrome. J Thromb Haemost (2021) 19(10):2546&#x2013;53. doi:&#xa0;10.1111/jth.15490</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/jth.15490</ArticleId><ArticleId IdType="pmc">PMC8420256</ArticleId><ArticleId IdType="pubmed">34375505</ArticleId></ArticleIdList></Reference><Reference><Citation>Khismatullin RR, Ponomareva AA, Nagaswami C, Ivaeva RA, Montone KT, Weisel JW, et al. . Pathology of Lung-Specific Thrombosis and Inflammation in COVID-19. J Thromb Haemost (2021) 19(12):3062&#x2013;72. doi:&#xa0;10.1111/jth.15532</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/jth.15532</ArticleId><ArticleId IdType="pmc">PMC8646730</ArticleId><ArticleId IdType="pubmed">34538029</ArticleId></ArticleIdList></Reference><Reference><Citation>Korompoki E, Gavriatopoulou M, Fotiou D, Ntanasis-Stathopoulos I, Dimopoulos MA, Terpos E. Late-Onset Hematological Complications Post COVID-19: An Emerging Medical Problem for the Hematologist. Am J Hematol (2022) 97(1):119&#x2013;28. doi:&#xa0;10.1002/ajh.26384</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/ajh.26384</ArticleId><ArticleId IdType="pmc">PMC8646944</ArticleId><ArticleId IdType="pubmed">34687462</ArticleId></ArticleIdList></Reference><Reference><Citation>Oudkerk M, B&#xfc;ller HR, Kuijpers D, van Es N, Oudkerk SF, McLoud T, et al. . Diagnosis, Prevention, and Treatment of Thromboembolic Complications in COVID-19: Report of the National Institute for Public Health of the Netherlands. Radiology (2020) 297(1):E216&#x2013;22. doi:&#xa0;10.1148/radiol.2020201629</Citation><ArticleIdList><ArticleId IdType="doi">10.1148/radiol.2020201629</ArticleId><ArticleId IdType="pmc">PMC7233406</ArticleId><ArticleId IdType="pubmed">32324101</ArticleId></ArticleIdList></Reference><Reference><Citation>Cheung PC, Eisch AR, Maleque N, Polly DM, Auld SC, Druey KM. Fatal Exacerbations of Systemic Capillary Leak Syndrome Complicating Coronavirus Disease. Emerg Infect Dis (2021) 27(10):2529&#x2013;34. doi:&#xa0;10.3201/eid2710.211155</Citation><ArticleIdList><ArticleId IdType="doi">10.3201/eid2710.211155</ArticleId><ArticleId IdType="pmc">PMC8462330</ArticleId><ArticleId IdType="pubmed">34314669</ArticleId></ArticleIdList></Reference><Reference><Citation>Lacout C, Rogez J, Orvain C, Nicot C, Rony L, Julien H, et al. . A New Diagnosis of Systemic Capillary Leak Syndrome on a Patient With COVID-19. Rheumatology (Oxford) (2021) 60(1):e19&#x2013;20. doi:&#xa0;10.1093/rheumatology/keaa606</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/rheumatology/keaa606</ArticleId><ArticleId IdType="pmc">PMC7543632</ArticleId><ArticleId IdType="pubmed">32940700</ArticleId></ArticleIdList></Reference><Reference><Citation>Veluswamy P, Wacker M, Stavridis D, Reichel T, Schmidt H, Scherner M, et al. . The SARS-CoV-2/Receptor Axis in Heart and Blood Vessels: A Crisp Update on COVID-19 Disease With Cardiovascular Complications. Viruses (2021) 13(7):1346. doi:&#xa0;10.3390/v13071346</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/v13071346</ArticleId><ArticleId IdType="pmc">PMC8310117</ArticleId><ArticleId IdType="pubmed">34372552</ArticleId></ArticleIdList></Reference><Reference><Citation>Gattinoni L, Chiumello D, Caironi P, Busana M, Romitti F, Brazzi L, et al. . COVID-19 Pneumonia: Different Respiratory Treatments for Different Phenotypes? Intensive Care Med (2020) 46(6):1099&#x2013;102. doi:&#xa0;10.1007/s00134-020-06033-2</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00134-020-06033-2</ArticleId><ArticleId IdType="pmc">PMC7154064</ArticleId><ArticleId IdType="pubmed">32291463</ArticleId></ArticleIdList></Reference><Reference><Citation>D&#x2019;Agnillo F, Walters KA, Xiao Y, Sheng ZM, Scherler K, Park J, et al. . Lung Epithelial and Endothelial Damage, Loss of Tissue Repair, Inhibition of Fibrinolysis, and Cellular Senescence in Fatal COVID-19. Sci Transl Med (2021) 13(620):eabj7790. doi:&#xa0;10.1126/scitranslmed.abj7790</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/scitranslmed.abj7790</ArticleId><ArticleId IdType="pmc">PMC11000440</ArticleId><ArticleId IdType="pubmed">34648357</ArticleId></ArticleIdList></Reference><Reference><Citation>Lund LC, Hallas J, Nielsen H, Koch A, Mogensen SH, Brun NC, et al. . Post-Acute Effects of SARS-CoV-2 Infection in Individuals Not Requiring Hospital Admission: A Danish Population-Based Cohort Study. Lancet Infect Dis (2021) 21(10):1373&#x2013;82. doi:&#xa0;10.1016/S1473-3099(21)00211-5</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S1473-3099(21)00211-5</ArticleId><ArticleId IdType="pmc">PMC8110209</ArticleId><ArticleId IdType="pubmed">33984263</ArticleId></ArticleIdList></Reference><Reference><Citation>Aranda J, Oriol I, Mart&#xed;n M, Feria L, V&#xe1;zquez N, Rhyman N, et al. . Long-Term Impact of COVID-19 Associated Acute Respiratory Distress Syndrome. J Infect (2021) 83(5):581&#x2013;8. doi:&#xa0;10.1016/j.jinf.2021.08.018</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jinf.2021.08.018</ArticleId><ArticleId IdType="pmc">PMC8363182</ArticleId><ArticleId IdType="pubmed">34400219</ArticleId></ArticleIdList></Reference><Reference><Citation>Milross L, Majo J, Cooper N, Kaye PM, Bayraktar O, Filby A, et al. . Post-Mortem Lung Tissue: The Fossil Record of the Pathophysiology and Immunopathology of Severe COVID-19. Lancet Respir Med (2022) 10(1):95&#x2013;106. doi:&#xa0;10.1016/S2213-2600(21)00408-2</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S2213-2600(21)00408-2</ArticleId><ArticleId IdType="pmc">PMC8641959</ArticleId><ArticleId IdType="pubmed">34871544</ArticleId></ArticleIdList></Reference><Reference><Citation>Jadaun PK, Chatterjee S. COVID-19 and Dys-Regulation of Pulmonary Endothelium: Implications for Vascular Remodeling. Cytokine Growth Factor Rev (2021) 63:69&#x2013;77. doi:&#xa0;10.1016/j.cytogfr.2021.10.003</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cytogfr.2021.10.003</ArticleId><ArticleId IdType="pmc">PMC9611904</ArticleId><ArticleId IdType="pubmed">34728151</ArticleId></ArticleIdList></Reference><Reference><Citation>Chilosi M, Poletti V, Ravaglia C, Rossi G, Dubini A, Piciucchi S, et al. . The Pathogenic Role of Epithelial and Endothelial Cells in Early-Phase COVID-19 Pneumonia: Victims and Partners in Crime. Mod Pathol (2021) 34(8):1444&#x2013;55. doi:&#xa0;10.1038/s41379-021-00808-8</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41379-021-00808-8</ArticleId><ArticleId IdType="pmc">PMC8058579</ArticleId><ArticleId IdType="pubmed">33883694</ArticleId></ArticleIdList></Reference><Reference><Citation>Teuwen LA, Geldhof V, Pasut A, Carmeliet P. COVID-19: The Vasculature Unleashed. Nat Rev Immunol (2020) 20(7):389&#x2013;91. doi:&#xa0;10.1038/s41577-020-0343-0</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41577-020-0343-0</ArticleId><ArticleId IdType="pmc">PMC7240244</ArticleId><ArticleId IdType="pubmed">32439870</ArticleId></ArticleIdList></Reference><Reference><Citation>Varga Z, Flammer AJ, Steiger P, Haberecker M, Andermatt R, Zinkernagel AS, et al. . Endothelial Cell Infection and Endotheliitis in COVID-19. Lancet (2020) 395(10234):1417&#x2013;8. doi:&#xa0;10.1016/S0140-6736(20)30937-5</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(20)30937-5</ArticleId><ArticleId IdType="pmc">PMC7172722</ArticleId><ArticleId IdType="pubmed">32325026</ArticleId></ArticleIdList></Reference><Reference><Citation>Pons S, Fodil S, Azoulay E, Zafrani L. The Vascular Endothelium: The Cornerstone of Organ Dysfunction in Severe SARS-CoV-2 Infection. Crit Care (2020) 24(1):353. doi:&#xa0;10.1186/s13054-020-03062-7</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13054-020-03062-7</ArticleId><ArticleId IdType="pmc">PMC7296907</ArticleId><ArticleId IdType="pubmed">32546188</ArticleId></ArticleIdList></Reference><Reference><Citation>Tarhini H, Recoing A, Bridier-Nahmias A, Rahi M, Lambert C, Martres P, et al. . Long-Term Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Infectiousness Among Three Immunocompromised Patients: From Prolonged Viral Shedding to SARS-CoV-2 Superinfection. J Infect Dis (2021) 223(9):1522&#x2013;7. doi:&#xa0;10.1093/infdis/jiab075</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/infdis/jiab075</ArticleId><ArticleId IdType="pmc">PMC7928754</ArticleId><ArticleId IdType="pubmed">33556961</ArticleId></ArticleIdList></Reference><Reference><Citation>Vardhana SA, Wolchok JD. The Many Faces of the Anti-COVID Immune Response. J Exp Med (2020) 217(6):e20200678. doi:&#xa0;10.1084/jem.20200678</Citation><ArticleIdList><ArticleId IdType="doi">10.1084/jem.20200678</ArticleId><ArticleId IdType="pmc">PMC7191310</ArticleId><ArticleId IdType="pubmed">32353870</ArticleId></ArticleIdList></Reference><Reference><Citation>Proal AD, VanElzakker MB. Long COVID or Post-Acute Sequelae of COVID-19 (PASC): An Overview of Biological Factors That May Contribute to Persistent Symptoms. Front Microbiol (2021) 12:698169. doi:&#xa0;10.3389/fmicb.2021.698169</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fmicb.2021.698169</ArticleId><ArticleId IdType="pmc">PMC8260991</ArticleId><ArticleId IdType="pubmed">34248921</ArticleId></ArticleIdList></Reference><Reference><Citation>Wu J, Liu X, Liu J, Liao H, Long S, Zhou N, et al. . Coronavirus Disease 2019 Test Results After Clinical Recovery and Hospital Discharge Among Patients in China. JAMA Netw Open (2020) 3(5):e209759. doi:&#xa0;10.1001/jamanetworkopen.2020.9759</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamanetworkopen.2020.9759</ArticleId><ArticleId IdType="pmc">PMC7244988</ArticleId><ArticleId IdType="pubmed">32442288</ArticleId></ArticleIdList></Reference><Reference><Citation>Long QX, Tang XJ, Shi QL, Li Q, Deng HJ, Yuan J, et al. . Clinical and Immunological Assessment of Asymptomatic SARS-CoV-2 Infections. Nat Med (2020) 26(8):1200&#x2013;4. doi:&#xa0;10.1038/s41591-020-0965-6</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41591-020-0965-6</ArticleId><ArticleId IdType="pubmed">32555424</ArticleId></ArticleIdList></Reference><Reference><Citation>Harvey WT, Carabelli AM, Jackson B, Gupta RK, Thomson EC, Harrison EM, et al. . SARS-CoV-2 Variants, Spike Mutations and Immune Escape. Nat Rev Microbiol (2021) 19(7):409&#x2013;24. doi:&#xa0;10.1038/s41579-021-00573-0</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41579-021-00573-0</ArticleId><ArticleId IdType="pmc">PMC8167834</ArticleId><ArticleId IdType="pubmed">34075212</ArticleId></ArticleIdList></Reference><Reference><Citation>Wajnberg A, Amanat F, Firpo A, Altman DR, Bailey MJ, Mansour M, et al. . Robust Neutralizing Antibodies to SARS-CoV-2 Infection Persist for Months. Science (2020) 370(6521):1227&#x2013;30. doi:&#xa0;10.1126/science.abd7728</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.abd7728</ArticleId><ArticleId IdType="pmc">PMC7810037</ArticleId><ArticleId IdType="pubmed">33115920</ArticleId></ArticleIdList></Reference><Reference><Citation>De Melo GD, Lazarini F, Levallois S, Hautefort C, Michel V, Larrous F, et al. . COVID-19-Associated Olfactory Dysfunction Reveals SARS-CoV-2 Neuroinvasion and Persistence in the Olfactory System. bioRxiv (2020) 2020:2020.11.18.388819. doi:&#xa0;10.1101/2020.11.18.388819</Citation><ArticleIdList><ArticleId IdType="doi">10.1101/2020.11.18.388819</ArticleId></ArticleIdList></Reference><Reference><Citation>Hu B, Guo H, Zhou P, Shi ZL. Characteristics of SARS-CoV-2 and COVID-19 [Published Correction Appears in Nat Rev Microbiol. 2022 Feb 23]. Nat Rev Microbiol (2021) 19(3):141&#x2013;54. doi:&#xa0;10.1038/s41579-020-00459-7</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41579-020-00459-7</ArticleId><ArticleId IdType="pmc">PMC7537588</ArticleId><ArticleId IdType="pubmed">33024307</ArticleId></ArticleIdList></Reference><Reference><Citation>Ravichandran KS. Beginnings of a Good Apoptotic Meal: The Find-Me and Eat-Me Signaling Pathways. Immunity (2011) 35(4):445&#x2013;55. doi:&#xa0;10.1016/j.immuni.2011.09.004</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.immuni.2011.09.004</ArticleId><ArticleId IdType="pmc">PMC3241945</ArticleId><ArticleId IdType="pubmed">22035837</ArticleId></ArticleIdList></Reference><Reference><Citation>Bagalkot V, Deiuliis JA, Rajagopalan S, Maiseyeu A. &#x201c;Eat Me&#x201d; Imaging and Therapy. Adv Drug Deliv Rev (2016) 99(Pt A):2&#x2013;11. doi:&#xa0;10.1016/j.addr.2016.01.009</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.addr.2016.01.009</ArticleId><ArticleId IdType="pmc">PMC4865253</ArticleId><ArticleId IdType="pubmed">26826436</ArticleId></ArticleIdList></Reference><Reference><Citation>Bridges JP, Vladar EK, Huang H, Mason RJ. Respiratory Epithelial Cell Responses to SARS-CoV-2 in COVID-19. Thorax (2022) 77(2):203&#x2013;9. doi:&#xa0;10.1136/thoraxjnl-2021-217561</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/thoraxjnl-2021-217561</ArticleId><ArticleId IdType="pmc">PMC9273148</ArticleId><ArticleId IdType="pubmed">34404754</ArticleId></ArticleIdList></Reference><Reference><Citation>Trougakos IP, Stamatelopoulos K, Terpos E, Tsitsilonis OE, Aivalioti E, Paraskevis D, et al. . Insights to SARS-CoV-2 Life Cycle, Pathophysiology, and Rationalized Treatments That Target COVID-19 Clinical Complications. J BioMed Sci (2021) 28(1):9. doi:&#xa0;10.1186/s12929-020-00703-5</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12929-020-00703-5</ArticleId><ArticleId IdType="pmc">PMC7801873</ArticleId><ArticleId IdType="pubmed">33435929</ArticleId></ArticleIdList></Reference><Reference><Citation>Wazny V, Siau A, Wu KX, Cheung C. Vascular Underpinning of COVID-19. Open Biol (2020) 10(8):200208. doi:&#xa0;10.1098/rsob.200208</Citation><ArticleIdList><ArticleId IdType="doi">10.1098/rsob.200208</ArticleId><ArticleId IdType="pmc">PMC7479931</ArticleId><ArticleId IdType="pubmed">32847471</ArticleId></ArticleIdList></Reference><Reference><Citation>Prasad M, Leon M, Lerman LO, Lerman A. Viral Endothelial Dysfunction: A Unifying Mechanism for COVID-19. Mayo Clin Proc (2021) 96(12):3099&#x2013;108. doi:&#xa0;10.1016/j.mayocp.2021.06.027</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.mayocp.2021.06.027</ArticleId><ArticleId IdType="pmc">PMC8373818</ArticleId><ArticleId IdType="pubmed">34863398</ArticleId></ArticleIdList></Reference><Reference><Citation>Higashikuni Y, Liu W, Obana T, Sata M. Pathogenic Basis of Thromboinflammation and Endothelial Injury in COVID-19: Current Findings and Therapeutic Implications. Int J Mol Sci (2021) 22(21):12081. doi:&#xa0;10.3390/ijms222112081</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijms222112081</ArticleId><ArticleId IdType="pmc">PMC8584434</ArticleId><ArticleId IdType="pubmed">34769508</ArticleId></ArticleIdList></Reference><Reference><Citation>Ma Z, Yang KY, Huang Y, Lui KO. Endothelial Contribution to COVID-19: An Update on Mechanisms and Therapeutic Implications. J Mol Cell Cardiol (2021) 164:69&#x2013;82. doi:&#xa0;10.1016/j.yjmcc.2021.11.010</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.yjmcc.2021.11.010</ArticleId><ArticleId IdType="pmc">PMC8610843</ArticleId><ArticleId IdType="pubmed">34838588</ArticleId></ArticleIdList></Reference><Reference><Citation>Kander T. Coagulation Disorder in COVID-19. Lancet Haematol (2020) 7(9):e630&#x2013;2. doi:&#xa0;10.1016/S2352-3026(20)30218-0</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S2352-3026(20)30218-0</ArticleId><ArticleId IdType="pmc">PMC7351400</ArticleId><ArticleId IdType="pubmed">32659213</ArticleId></ArticleIdList></Reference><Reference><Citation>Zarrilli G, Angerilli V, Businello G, Sbaraglia M, Traverso G, Fortarezza F, et al. . The Immunopathological and Histological Landscape of COVID-19-Mediated Lung Injury. Int J Mol Sci (2021) 22(2):974. doi:&#xa0;10.3390/ijms22020974</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijms22020974</ArticleId><ArticleId IdType="pmc">PMC7835817</ArticleId><ArticleId IdType="pubmed">33478107</ArticleId></ArticleIdList></Reference><Reference><Citation>Deinhardt-Emmer S, Wittschieber D, Sanft J, Kleemann S, Elschner S, Haupt KF, et al. . Early Postmortem Mapping Of SARS-Cov-2 RNA in Patients With COVID-19 and the Correlation With Tissue Damage. Elife (2021) 10:e60361. doi:&#xa0;10.7554/eLife.60361</Citation><ArticleIdList><ArticleId IdType="doi">10.7554/eLife.60361</ArticleId><ArticleId IdType="pmc">PMC8009677</ArticleId><ArticleId IdType="pubmed">33781385</ArticleId></ArticleIdList></Reference><Reference><Citation>Mo X, Jian W, Su Z, Chen M, Peng H, Peng P, et al. . Abnormal Pulmonary Function in COVID-19 Patients at Time of Hospital Discharge. Eur Respir J (2020) 55(6):2001217. doi:&#xa0;10.1183/13993003.01217-2020</Citation><ArticleIdList><ArticleId IdType="doi">10.1183/13993003.01217-2020</ArticleId><ArticleId IdType="pmc">PMC7236826</ArticleId><ArticleId IdType="pubmed">32381497</ArticleId></ArticleIdList></Reference><Reference><Citation>Huang Y, Tan C, Wu J, Chen M, Wang Z, Luo L, et al. . Impact of Coronavirus Disease 2019 on Pulmonary Function in Early Convalescence Phase. Respir Res (2020) 21(1):163. doi:&#xa0;10.1186/s12931-020-01429-6</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12931-020-01429-6</ArticleId><ArticleId IdType="pmc">PMC7323373</ArticleId><ArticleId IdType="pubmed">32600344</ArticleId></ArticleIdList></Reference><Reference><Citation>Fajgenbaum DC, June CH. Cytokine Storm. N Engl J Med (2020) 383(23):2255&#x2013;73. doi:&#xa0;10.1056/NEJMra2026131</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMra2026131</ArticleId><ArticleId IdType="pmc">PMC7727315</ArticleId><ArticleId IdType="pubmed">33264547</ArticleId></ArticleIdList></Reference><Reference><Citation>Leisman DE, Ronner L, Pinotti R, Taylor MD, Sinha P, Calfee CS, et al. . Cytokine Elevation in Severe and Critical COVID-19: A Rapid Systematic Review, Meta-Analysis, and Comparison With Other Inflammatory Syndromes. Lancet Respir Med (2020) 8(12):1233&#x2013;44. doi:&#xa0;10.1016/S2213-2600(20)30404-5</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S2213-2600(20)30404-5</ArticleId><ArticleId IdType="pmc">PMC7567529</ArticleId><ArticleId IdType="pubmed">33075298</ArticleId></ArticleIdList></Reference><Reference><Citation>Gao YM, Xu G, Wang B, Liu BC. Cytokine Storm Syndrome in Coronavirus Disease 2019: A Narrative Review. J Intern Med (2021) 289(2):147&#x2013;61. doi:&#xa0;10.1111/joim.13144</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/joim.13144</ArticleId><ArticleId IdType="pmc">PMC7404514</ArticleId><ArticleId IdType="pubmed">32696489</ArticleId></ArticleIdList></Reference><Reference><Citation>Kang S, Tanaka T, Inoue H, Ono C, Hashimoto S, Kioi Y, et al. . IL-6 Trans-Signaling Induces Plasminogen Activator Inhibitor-1 From Vascular Endothelial Cells in Cytokine Release Syndrome. Proc Natl Acad Sci USA (2020) 17(36):22351&#x2013;6. doi:&#xa0;10.1073/pnas.2010229117</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.2010229117</ArticleId><ArticleId IdType="pmc">PMC7486751</ArticleId><ArticleId IdType="pubmed">32826331</ArticleId></ArticleIdList></Reference><Reference><Citation>Kaur S, Bansal R, Kollimuttathuillam S, Gowda AM, Singh B, Mehta D, et al. . The Looming Storm: Blood and Cytokines in COVID-19. Blood Rev (2021) 46:100743. doi:&#xa0;10.1016/j.blre.2020.100743</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.blre.2020.100743</ArticleId><ArticleId IdType="pmc">PMC7431319</ArticleId><ArticleId IdType="pubmed">32829962</ArticleId></ArticleIdList></Reference><Reference><Citation>Caricchio R, Gallucci M, Dass C, Zhang X, Gallucci S, Fleece D, et al. . Preliminary Predictive Criteria for COVID-19 Cytokine Storm. Ann Rheum Dis (2021) 80(1):88&#x2013;95. doi:&#xa0;10.1136/annrheumdis-2020-218323</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/annrheumdis-2020-218323</ArticleId><ArticleId IdType="pubmed">32978237</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen R, Lan Z, Ye J, Pang L, Liu Y, Wu W, et al. . Cytokine Storm: The Primary Determinant for the Pathophysiological Evolution of COVID-19 Deterioration. Front Immunol (2021) 12:589095. doi:&#xa0;10.3389/fimmu.2021.589095</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2021.589095</ArticleId><ArticleId IdType="pmc">PMC8115911</ArticleId><ArticleId IdType="pubmed">33995341</ArticleId></ArticleIdList></Reference><Reference><Citation>Mangalmurti N, Hunter CA. Cytokine Storms: Understanding COVID-19. Immunity (2020) 53(1):19&#x2013;25. doi:&#xa0;10.1016/j.immuni.2020.06.017</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.immuni.2020.06.017</ArticleId><ArticleId IdType="pmc">PMC7321048</ArticleId><ArticleId IdType="pubmed">32610079</ArticleId></ArticleIdList></Reference><Reference><Citation>Shah A, Frost JN, Aaron L, Donovan K, Drakesmith H, Collaborators . Systemic Hypoferremia and Severity of Hypoxemic Respiratory Failure in COVID-19. Crit Care (2020) 24(1):320. doi:&#xa0;10.1186/s13054-020-03051-w</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13054-020-03051-w</ArticleId><ArticleId IdType="pmc">PMC7280775</ArticleId><ArticleId IdType="pubmed">32517773</ArticleId></ArticleIdList></Reference><Reference><Citation>Rauch A, Dupont A, Goutay J, Caplan M, Staessens S, Moussa M, et al. . Endotheliopathy Is Induced by Plasma From Critically Ill Patients and Associated With Organ Failure in Severe COVID-19. Circulation (2020) 142(19):1881&#x2013;4. doi:&#xa0;10.1161/CIRCULATIONAHA.120.050907</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/CIRCULATIONAHA.120.050907</ArticleId><ArticleId IdType="pmc">PMC7643783</ArticleId><ArticleId IdType="pubmed">32970476</ArticleId></ArticleIdList></Reference><Reference><Citation>Ackermann M, Verleden SE, Kuehnel M, Haverich A, Welte T, Laenger F, et al. . Pulmonary Vascular Endothelialitis, Thrombosis, and Angiogenesis in COVID-19. N Engl J Med (2020) 383(2):120&#x2013;8. doi:&#xa0;10.1056/NEJMoa2015432</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMoa2015432</ArticleId><ArticleId IdType="pmc">PMC7412750</ArticleId><ArticleId IdType="pubmed">32437596</ArticleId></ArticleIdList></Reference><Reference><Citation>Tan BK, Mainbourg S, Friggeri A, Bertoletti L, Douplat M, Dargaud Y, et al. . Arterial and Venous Thromboembolism in COVID-19: A Study-Level Meta-Analysis. Thorax (2021) 76(10):970&#x2013;9. doi:&#xa0;10.1136/thoraxjnl-2020-215383</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/thoraxjnl-2020-215383</ArticleId><ArticleId IdType="pubmed">33622981</ArticleId></ArticleIdList></Reference><Reference><Citation>Bellmunt-Montoya S, Riera C, Gil D, Rodr&#xed;guez M, Garc&#xed;a-Reyes M, Mart&#xed;nez-Carnovale L, et al. . COVID-19 Infection in Critically Ill Patients Carries a High Risk of Venous Thrombo-Embolism. Eur J Vasc Endovasc Surg (2021) 61(4):628&#x2013;34. doi:&#xa0;10.1016/j.ejvs.2020.12.015</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ejvs.2020.12.015</ArticleId><ArticleId IdType="pmc">PMC7757344</ArticleId><ArticleId IdType="pubmed">33583710</ArticleId></ArticleIdList></Reference><Reference><Citation>McFadyen JD, Stevens H, Peter K. The Emerging Threat of (Micro)Thrombosis in COVID-19 and Its Therapeutic Implications. Circ Res (2020) 127(4):571&#x2013;87. doi:&#xa0;10.1161/CIRCRESAHA.120.317447</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/CIRCRESAHA.120.317447</ArticleId><ArticleId IdType="pmc">PMC7386875</ArticleId><ArticleId IdType="pubmed">32586214</ArticleId></ArticleIdList></Reference><Reference><Citation>Voicu S, Ketfi C, St&#xe9;panian A, Chousterman BG, Mohamedi N, Siguret V, et al. . Pathophysiological Processes Underlying the High Prevalence of Deep Vein Thrombosis in Critically Ill COVID-19 Patients. Front Physiol (2021) 11:608788. doi:&#xa0;10.3389/fphys.2020.608788</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fphys.2020.608788</ArticleId><ArticleId IdType="pmc">PMC7820906</ArticleId><ArticleId IdType="pubmed">33488398</ArticleId></ArticleIdList></Reference><Reference><Citation>Dhawan RT, Gopalan D, Howard L, Vicente A, Park M, Manalan K, et al. . Beyond the Clot: Perfusion Imaging of the Pulmonary Vasculature After COVID-19. Lancet Respir Med (2021) 9(1):107&#x2013;16. doi:&#xa0;10.1016/S2213-2600(20)30407-0</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S2213-2600(20)30407-0</ArticleId><ArticleId IdType="pmc">PMC7833494</ArticleId><ArticleId IdType="pubmed">33217366</ArticleId></ArticleIdList></Reference><Reference><Citation>Long Q, Li J, Hu X, Bai Y, Zheng Y, Gao Z. Follow-Ups on Persistent Symptoms and Pulmonary Function Among Post-Acute COVID-19 Patients: A Systematic Review and Meta-Analysis. Front Med (Lausanne) (2021) 8:702635. doi:&#xa0;10.3389/fmed.2021.702635</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fmed.2021.702635</ArticleId><ArticleId IdType="pmc">PMC8448290</ArticleId><ArticleId IdType="pubmed">34540862</ArticleId></ArticleIdList></Reference><Reference><Citation>Sivan M, Rayner C, Delaney B. Fresh Evidence of the Scale and Scope of Long COVID. BMJ (2021) 373:n853. doi:&#xa0;10.1136/bmj.n853</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmj.n853</ArticleId><ArticleId IdType="pubmed">33795224</ArticleId></ArticleIdList></Reference><Reference><Citation>Al-Aly Z, Xie Y, Bowe B. High-Dimensional Characterization of Post-Acute Sequelae of COVID-19. Nature (2021) 594(7862):259&#x2013;64. doi:&#xa0;10.1038/s41586-021-03553-9</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41586-021-03553-9</ArticleId><ArticleId IdType="pubmed">33887749</ArticleId></ArticleIdList></Reference><Reference><Citation>Yomogida K, Zhu S, Rubino F, Figueroa W, Balanji N, Holman E. Post-Acute Sequelae of SARS-CoV-2 Infection Among Adults Aged &#x2265;18 Years - Long Beach, California, April 1-December 10, 2020. MMWR Morb Mortal Wkly Rep (2021) 70(37):1274&#x2013;7. doi:&#xa0;10.15585/mmwr.mm7037a2</Citation><ArticleIdList><ArticleId IdType="doi">10.15585/mmwr.mm7037a2</ArticleId><ArticleId IdType="pmc">PMC8445372</ArticleId><ArticleId IdType="pubmed">34529639</ArticleId></ArticleIdList></Reference><Reference><Citation>Daugherty SE, Guo Y, Heath K, Dasmari&#xf1;as MC, Jubilo KG, Samranvedhya J, et al. . Risk of Clinical Sequelae After the Acute Phase of SARS-CoV-2 Infection: Retrospective Cohort Study. BMJ (2021) 373:n1098. doi:&#xa0;10.1136/bmj.n1098</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmj.n1098</ArticleId><ArticleId IdType="pmc">PMC8132065</ArticleId><ArticleId IdType="pubmed">34011492</ArticleId></ArticleIdList></Reference><Reference><Citation>Anaya JM, Rojas M, Salinas ML, Rodr&#xed;guez Y, Roa G, Lozano M, et al. . Post-COVID Syndrome. A Case Series and Comprehensive Review. Autoimmun Rev (2021) 20(11):102947. doi:&#xa0;10.1016/j.autrev.2021.102947</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.autrev.2021.102947</ArticleId><ArticleId IdType="pmc">PMC8428988</ArticleId><ArticleId IdType="pubmed">34509649</ArticleId></ArticleIdList></Reference><Reference><Citation>Michelen M, Manoharan L, Elkheir N, Cheng V, Dagens A, Hastie C, et al. . Characterising Long COVID: A Living Systematic Review. BMJ Glob Health (2021) 6(9):e005427. doi:&#xa0;10.1136/bmjgh-2021-005427</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmjgh-2021-005427</ArticleId><ArticleId IdType="pmc">PMC8478580</ArticleId><ArticleId IdType="pubmed">34580069</ArticleId></ArticleIdList></Reference><Reference><Citation>O&#x2019;Donnell JS, Peyvandi F, Martin-Loeches I. Pulmonary Immuno-Thrombosis in COVID-19 ARDS Pathogenesis. Intensive Care Med (2021) 47(8):899&#x2013;902. doi:&#xa0;10.1007/s00134-021-06419-w</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00134-021-06419-w</ArticleId><ArticleId IdType="pmc">PMC8164686</ArticleId><ArticleId IdType="pubmed">34052905</ArticleId></ArticleIdList></Reference><Reference><Citation>Fang XZ, Wang YX, Xu JQ, He YJ, Peng ZK, Shang Y. Immunothrombosis in Acute Respiratory Dysfunction of COVID-19. Front Immunol (2021) 12:651545. doi:&#xa0;10.3389/fimmu.2021.651545</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2021.651545</ArticleId><ArticleId IdType="pmc">PMC8207198</ArticleId><ArticleId IdType="pubmed">34149692</ArticleId></ArticleIdList></Reference><Reference><Citation>Lim MS, Mcrae S. COVID-19 and Immunothrombosis: Pathophysiology and Therapeutic Implications. Crit Rev Oncol Hematol (2021) 168:103529. doi:&#xa0;10.1016/j.critrevonc.2021.103529</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.critrevonc.2021.103529</ArticleId><ArticleId IdType="pmc">PMC8596655</ArticleId><ArticleId IdType="pubmed">34800652</ArticleId></ArticleIdList></Reference><Reference><Citation>Gattinoni L, Coppola S, Cressoni M, Busana M, Rossi S, Chiumello D. COVID-19 Does Not Lead to a &#x201c;Typical&#x201d; Acute Respiratory Distress Syndrome. Am J Respir Crit Care Med (2020) 201(10):1299&#x2013;300. doi:&#xa0;10.1164/rccm.202003-0817LE</Citation><ArticleIdList><ArticleId IdType="doi">10.1164/rccm.202003-0817LE</ArticleId><ArticleId IdType="pmc">PMC7233352</ArticleId><ArticleId IdType="pubmed">32228035</ArticleId></ArticleIdList></Reference><Reference><Citation>Poor HD. Pulmonary Thrombosis and Thromboembolism in COVID-19. Chest (2021) 160(4):1471&#x2013;80. doi:&#xa0;10.1016/j.chest.2021.06.016</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.chest.2021.06.016</ArticleId><ArticleId IdType="pmc">PMC8213519</ArticleId><ArticleId IdType="pubmed">34153340</ArticleId></ArticleIdList></Reference><Reference><Citation>Magro C, Mulvey JJ, Berlin D, Nuovo G, Salvatore S, Harp J, et al. . Complement Associated Microvascular Injury and Thrombosis in the Pathogenesis of Severe COVID-19 Infection: A Report of Five Cases. Transl Res (2020) 220:1&#x2013;13. doi:&#xa0;10.1016/j.trsl.2020.04.007</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.trsl.2020.04.007</ArticleId><ArticleId IdType="pmc">PMC7158248</ArticleId><ArticleId IdType="pubmed">32299776</ArticleId></ArticleIdList></Reference><Reference><Citation>Synowiec A, Szczepa&#x144;ski A, Barreto-Duran E, Lie LK, Pyrc K. Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2): A Systemic Infection. Clin Microbiol Rev (2021) 34(2):e00133-20. doi:&#xa0;10.1128/CMR.00133-20</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/CMR.00133-20</ArticleId><ArticleId IdType="pmc">PMC7849242</ArticleId><ArticleId IdType="pubmed">33441314</ArticleId></ArticleIdList></Reference><Reference><Citation>Writing Committee for the COMEBAC Study Group. Morin L, Savale L, Pham T, Colle R, Figueiredo S, et al. . Four-Month Clinical Status of a Cohort of Patients After Hospitalization for COVID-19. JAMA (2021) 325(15):1525&#x2013;34. doi:&#xa0;10.1001/jama.2021.3331</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jama.2021.3331</ArticleId><ArticleId IdType="pmc">PMC7970386</ArticleId><ArticleId IdType="pubmed">33729425</ArticleId></ArticleIdList></Reference><Reference><Citation>Antonio GE, Wong KT, Hui DS, Wu A, Lee N, Yuen EH, et al. . Thin-Section CT in Patients With Severe Acute Respiratory Syndrome Following Hospital Discharge: Preliminary Experience. Radiology (2003) 228(3):810&#x2013;5. doi:&#xa0;10.1148/radiol.2283030726</Citation><ArticleIdList><ArticleId IdType="doi">10.1148/radiol.2283030726</ArticleId><ArticleId IdType="pubmed">12805557</ArticleId></ArticleIdList></Reference><Reference><Citation>Das KM, Lee EY, Singh R, Enani MA, Al Dossari K, Van Gorkom K, et al. . Follow-Up Chest Radiographic Findings in Patients With MERS-CoV After Recovery. Indian J Radiol Imaging (2017) 27(3):342&#x2013;9. doi:&#xa0;10.4103/ijri.IJRI_469_16</Citation><ArticleIdList><ArticleId IdType="doi">10.4103/ijri.IJRI_469_16</ArticleId><ArticleId IdType="pmc">PMC5644332</ArticleId><ArticleId IdType="pubmed">29089687</ArticleId></ArticleIdList></Reference><Reference><Citation>Norooznezhad AH, Mansouri K. Endothelial Cell Dysfunction, Coagulation, and Angiogenesis in Coronavirus Disease 2019 (COVID-19). Microvasc Res (2021) 137:104188. doi:&#xa0;10.1016/j.mvr.2021.104188</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.mvr.2021.104188</ArticleId><ArticleId IdType="pmc">PMC8135191</ArticleId><ArticleId IdType="pubmed">34022205</ArticleId></ArticleIdList></Reference><Reference><Citation>Libby P, L&#xfc;scher T. COVID-19 Is, in the End, an Endothelial Disease. Eur Heart J (2020) 41(32):3038&#x2013;44. doi:&#xa0;10.1093/eurheartj/ehaa623</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/eurheartj/ehaa623</ArticleId><ArticleId IdType="pmc">PMC7470753</ArticleId><ArticleId IdType="pubmed">32882706</ArticleId></ArticleIdList></Reference><Reference><Citation>Goshua G, Pine AB, Meizlish ML, Chang CH, Zhang H, Bahel P, et al. . Endotheliopathy in COVID-19-Associated Coagulopathy: Evidence From a Single-Centre, Cross-Sectional Study. Lancet Haematol (2020) 7(8):e575&#x2013;82. doi:&#xa0;10.1016/S2352-3026(20)30216-7</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S2352-3026(20)30216-7</ArticleId><ArticleId IdType="pmc">PMC7326446</ArticleId><ArticleId IdType="pubmed">32619411</ArticleId></ArticleIdList></Reference><Reference><Citation>Pasini E, Corsetti G, Romano C, Scarabelli TM, Chen-Scarabelli C, Saravolatz L, et al. . Serum Metabolic Profile in Patients With Long-Covid (PASC) Syndrome: Clinical Implications. Front Med (Lausanne) (2021) 8:714426. doi:&#xa0;10.3389/fmed.2021.714426</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fmed.2021.714426</ArticleId><ArticleId IdType="pmc">PMC8339407</ArticleId><ArticleId IdType="pubmed">34368201</ArticleId></ArticleIdList></Reference><Reference><Citation>de Candia P, Prattichizzo F, Garavelli S, Matarese G. T Cells: Warriors of SARS-CoV-2 Infection. Trends Immunol (2021) 42(1):18&#x2013;30. doi:&#xa0;10.1016/j.it.2020.11.002</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.it.2020.11.002</ArticleId><ArticleId IdType="pmc">PMC7664351</ArticleId><ArticleId IdType="pubmed">33277181</ArticleId></ArticleIdList></Reference><Reference><Citation>Jarjour NN, Masopust D, Jameson SC. T Cell Memory: Understanding COVID-19. Immunity (2021) 54(1):14&#x2013;8. doi:&#xa0;10.1016/j.immuni.2020.12.009</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.immuni.2020.12.009</ArticleId><ArticleId IdType="pmc">PMC7749639</ArticleId><ArticleId IdType="pubmed">33406391</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen W, Pan JY. Anatomical and Pathological Observation and Analysis of SARS and COVID-19: Microthrombosis Is the Main Cause of Death. Biol Proced Online (2021) 23(1):4. doi:&#xa0;10.1186/s12575-021-00142-y</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12575-021-00142-y</ArticleId><ArticleId IdType="pmc">PMC7816139</ArticleId><ArticleId IdType="pubmed">33472576</ArticleId></ArticleIdList></Reference><Reference><Citation>Loo J, Spittle DA, Newnham M. COVID-19, Immunothrombosis and Venous Thromboembolism: Biological Mechanisms. Thorax (2021) 76(4):412&#x2013;20. doi:&#xa0;10.1136/thoraxjnl-2020-216243</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/thoraxjnl-2020-216243</ArticleId><ArticleId IdType="pubmed">33408195</ArticleId></ArticleIdList></Reference><Reference><Citation>Grobler C, Maphumulo SC, Grobbelaar LM, Bredenkamp JC, Laubscher GJ, Lourens PJ, et al. . COVID-19: The Rollercoaster of Fibrin(Ogen), D-Dimer, Von Willebrand Factor, P-Selectin and Their Interactions With Endothelial Cells, Platelets and Erythrocytes. Int J Mol Sci (2020) 21(14):5168. doi:&#xa0;10.3390/ijms21145168</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijms21145168</ArticleId><ArticleId IdType="pmc">PMC7403995</ArticleId><ArticleId IdType="pubmed">32708334</ArticleId></ArticleIdList></Reference><Reference><Citation>Bevers EM, Williamson PL. Getting to the Outer Leaflet: Physiology of Phosphatidylserine Exposure at the Plasma Membrane. Physiol Rev (2016) 96(2):605&#x2013;45. doi:&#xa0;10.1152/physrev.00020.2015</Citation><ArticleIdList><ArticleId IdType="doi">10.1152/physrev.00020.2015</ArticleId><ArticleId IdType="pubmed">26936867</ArticleId></ArticleIdList></Reference><Reference><Citation>Langer F, Ruf W. Synergies of Phosphatidylserine and Protein Disulfide Isomerase in Tissue Factor Activation. Thromb Haemost (2014) 111(4):590&#x2013;7. doi:&#xa0;10.1160/TH13-09-0802</Citation><ArticleIdList><ArticleId IdType="doi">10.1160/TH13-09-0802</ArticleId><ArticleId IdType="pmc">PMC4270292</ArticleId><ArticleId IdType="pubmed">24452853</ArticleId></ArticleIdList></Reference><Reference><Citation>Hanayama R, Tanaka M, Miwa K, Shinohara A, Iwamatsu A, Nagata S. Identification of a Factor That Links Apoptotic Cells to Phagocytes. Nature (2002) 417(6885):182&#x2013;7. doi:&#xa0;10.1038/417182a</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/417182a</ArticleId><ArticleId IdType="pubmed">12000961</ArticleId></ArticleIdList></Reference><Reference><Citation>Fricker M, Neher JJ, Zhao JW, Th&#xe9;ry C, Tolkovsky AM, Brown GC. MFG-E8 Mediates Primary Phagocytosis of Viable Neurons During Neuroinflammation. J Neurosci (2012) 32(8):2657&#x2013;66. doi:&#xa0;10.1523/JNEUROSCI.4837-11.2012</Citation><ArticleIdList><ArticleId IdType="doi">10.1523/JNEUROSCI.4837-11.2012</ArticleId><ArticleId IdType="pmc">PMC3312099</ArticleId><ArticleId IdType="pubmed">22357850</ArticleId></ArticleIdList></Reference><Reference><Citation>Barrett TJ, Lee AH, Xia Y, Lin LH, Black M, Cotzia P, et al. . Platelet and Vascular Biomarkers Associate With Thrombosis and Death in Coronavirus Disease. Circ Res (2020) 127(7):945&#x2013;7. doi:&#xa0;10.1161/CIRCRESAHA.120.317803</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/CIRCRESAHA.120.317803</ArticleId><ArticleId IdType="pmc">PMC7478197</ArticleId><ArticleId IdType="pubmed">32757722</ArticleId></ArticleIdList></Reference><Reference><Citation>Barrett TJ, Lee A, Xia Y, Lin L, Black M, Cotzia P, et al. . Abstract 15888: Platelet Activation Is Associated With All-Cause Mortality in Patients With COVID-19. Circulation (2020) 142(Suppl_3):A15888&#x2013;A. doi:&#xa0;10.1161/circ.142.suppl_3.15888</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/circ.142.suppl_3.15888</ArticleId></ArticleIdList></Reference><Reference><Citation>Puhm F, Flamand L, Boilard E. Platelet Extracellular Vesicles in COVID-19: Potential Markers and Makers. J Leukoc Biol (2022) 111(1):63&#x2013;74. doi:&#xa0;10.1002/JLB.3MIR0221-100R</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/JLB.3MIR0221-100R</ArticleId><ArticleId IdType="pmc">PMC8667644</ArticleId><ArticleId IdType="pubmed">34730839</ArticleId></ArticleIdList></Reference><Reference><Citation>Balbi C, Burrello J, Bolis S, Lazzarini E, Biemmi V, Pianezzi E, et al. . Circulating Extracellular Vesicles Are Endowed With Enhanced Procoagulant Activity in SARS-CoV-2 Infection. EBioMedicine (2021) 67:103369. doi:&#xa0;10.1016/j.ebiom.2021.103369</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ebiom.2021.103369</ArticleId><ArticleId IdType="pmc">PMC8104913</ArticleId><ArticleId IdType="pubmed">33971404</ArticleId></ArticleIdList></Reference><Reference><Citation>Georgescu A, Simionescu M. Extracellular Vesicles: Versatile Nanomediators, Potential Biomarkers and Therapeutic Agents in Atherosclerosis and COVID-19-Related Thrombosis. Int J Mol Sci (2021) 22(11):5967. doi:&#xa0;10.3390/ijms22115967</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijms22115967</ArticleId><ArticleId IdType="pmc">PMC8198837</ArticleId><ArticleId IdType="pubmed">34073119</ArticleId></ArticleIdList></Reference><Reference><Citation>Rosell A, Havervall S, von Meijenfeldt F, Hisada Y, Aguilera K, Grover SP, et al. . Patients With COVID-19 Have Elevated Levels of Circulating Extracellular Vesicle Tissue Factor Activity That Is Associated With Severity and Mortality-Brief Report. Arterioscler Thromb Vasc Biol (2021) 41(2):878&#x2013;82. doi:&#xa0;10.1161/ATVBAHA.120.315547</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/ATVBAHA.120.315547</ArticleId><ArticleId IdType="pmc">PMC7837685</ArticleId><ArticleId IdType="pubmed">33267656</ArticleId></ArticleIdList></Reference><Reference><Citation>Zaid Y, Puhm F, Allaeys I, Naya A, Oudghiri M, Khalki L, et al. . Platelets Can Associate With SARS-CoV-2 RNA and Are Hyperactivated in COVID-19. Circ Res (2020) 127(11):1404&#x2013;18. doi:&#xa0;10.1161/CIRCRESAHA.120.317703</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/CIRCRESAHA.120.317703</ArticleId><ArticleId IdType="pmc">PMC7641188</ArticleId><ArticleId IdType="pubmed">32938299</ArticleId></ArticleIdList></Reference><Reference><Citation>Rausch L, Lutz K, Schifferer M, Winheim E, Gruber R, Oesterhaus EF, et al. . Binding of Phosphatidylserine-Positive Microparticles by Pbmcs Classifies Disease Severity in COVID-19 Patients. J Extracell Vesicles (2021) 10(14):e12173. doi:&#xa0;10.1002/jev2.12173</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/jev2.12173</ArticleId><ArticleId IdType="pmc">PMC8636722</ArticleId><ArticleId IdType="pubmed">34854246</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang Y, Xiao M, Zhang S, Xia P, Cao W, Jiang W, et al. . Coagulopathy and Antiphospholipid Antibodies in Patients With COVID-19. N Engl J Med (2020) 382(17):e38. doi:&#xa0;10.1056/NEJMc2007575</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMc2007575</ArticleId><ArticleId IdType="pmc">PMC7161262</ArticleId><ArticleId IdType="pubmed">32268022</ArticleId></ArticleIdList></Reference><Reference><Citation>Semeraro F, Ammollo CT, Esmon NL, Esmon CT. Histones Induce Phosphatidylserine Exposure and a Procoagulant Phenotype in Human Red Blood Cells. J Thromb Haemost (2014) 12(10):1697&#x2013;702. doi:&#xa0;10.1111/jth.12677</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/jth.12677</ArticleId><ArticleId IdType="pmc">PMC4194154</ArticleId><ArticleId IdType="pubmed">25069624</ArticleId></ArticleIdList></Reference><Reference><Citation>Yeung T, Gilbert GE, Shi J, Silvius J, Kapus A, Grinstein S. Membrane Phosphatidylserine Regulates Surface Charge and Protein Localization. Science (2008) 319(5860):210&#x2013;3. doi:&#xa0;10.1126/science.1152066</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.1152066</ArticleId><ArticleId IdType="pubmed">18187657</ArticleId></ArticleIdList></Reference><Reference><Citation>Krishnamachary B, Cook C, Kumar A, Spikes L, Chalise P, Dhillon NK. Extracellular Vesicle-Mediated Endothelial Apoptosis and EV-Associated Proteins Correlate With COVID-19 Disease Severity. J Extracell Vesicles (2021) 10(9):e12117. doi:&#xa0;10.1002/jev2.12117</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/jev2.12117</ArticleId><ArticleId IdType="pmc">PMC8254805</ArticleId><ArticleId IdType="pubmed">34262673</ArticleId></ArticleIdList></Reference><Reference><Citation>Arga&#xf1;araz GA, Palmeira JDF, Arga&#xf1;araz ER. Phosphatidylserine Inside Out: A Possible Underlying Mechanism in the Inflammation and Coagulation Abnormalities of COVID-19. Cell Commun Signal (2020) 18(1):190. doi:&#xa0;10.1186/s12964-020-00687-7</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12964-020-00687-7</ArticleId><ArticleId IdType="pmc">PMC7765775</ArticleId><ArticleId IdType="pubmed">33357215</ArticleId></ArticleIdList></Reference><Reference><Citation>Ma R, Xie R, Yu C, Si Y, Wu X, Zhao L, et al. . Phosphatidylserine-Mediated Platelet Clearance by Endothelium Decreases Platelet Aggregates and Procoagulant Activity in Sepsis. Sci Rep (2017) 7(1):4978. doi:&#xa0;10.1038/s41598-017-04773-8</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-017-04773-8</ArticleId><ArticleId IdType="pmc">PMC5504060</ArticleId><ArticleId IdType="pubmed">28694452</ArticleId></ArticleIdList></Reference><Reference><Citation>Gao C, Xie R, Yu C, Wang Q, Shi F, Yao C, et al. . Procoagulant Activity of Erythrocytes and Platelets Through Phosphatidylserine Exposure and Microparticles Release in Patients With Nephrotic Syndrome. Thromb Haemost (2012) 107(4):681&#x2013;9. doi:&#xa0;10.1160/TH11-09-0673</Citation><ArticleIdList><ArticleId IdType="doi">10.1160/TH11-09-0673</ArticleId><ArticleId IdType="pubmed">22370875</ArticleId></ArticleIdList></Reference><Reference><Citation>Althaus K, Marini I, Zlamal J, Pelzl L, Singh A, H&#xe4;berle H, et al. . Antibody-Induced Procoagulant Platelets in Severe COVID-19 Infection. Blood (2021) 137(8):1061&#x2013;71. doi:&#xa0;10.1182/blood.2020008762</Citation><ArticleIdList><ArticleId IdType="doi">10.1182/blood.2020008762</ArticleId><ArticleId IdType="pmc">PMC7791311</ArticleId><ArticleId IdType="pubmed">33512415</ArticleId></ArticleIdList></Reference><Reference><Citation>Fu Y, Zhou J, Li H, Cao F, Su Y, Fan S, et al. . Daunorubicin Induces Procoagulant Activity of Cultured Endothelial Cells Through Phosphatidylserine Exposure and Microparticles Release. Thromb Haemost (2010) 104(6):1235&#x2013;41. doi:&#xa0;10.1160/TH10-02-0102</Citation><ArticleIdList><ArticleId IdType="doi">10.1160/TH10-02-0102</ArticleId><ArticleId IdType="pubmed">20886178</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhou J, Shi J, Hou J, Cao F, Zhang Y, Rasmussen JT, et al. . Phosphatidylserine Exposure and Procoagulant Activity in Acute Promyelocytic Leukemia. J&#xa0;Thromb Haemost (2010) 8(4):773&#x2013;82. doi:&#xa0;10.1111/j.1538-7836.2010.03763.x</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1538-7836.2010.03763.x</ArticleId><ArticleId IdType="pubmed">20102487</ArticleId></ArticleIdList></Reference><Reference><Citation>Cao M, Li T, He Z, Wang L, Yang X, Kou Y, et al. . Promyelocytic Extracellular Chromatin Exacerbates Coagulation and Fibrinolysis in Acute Promyelocytic Leukemia. Blood (2017) 129(13):1855&#x2013;64. doi:&#xa0;10.1182/blood-2016-09-739334</Citation><ArticleIdList><ArticleId IdType="doi">10.1182/blood-2016-09-739334</ArticleId><ArticleId IdType="pmc">PMC5374289</ArticleId><ArticleId IdType="pubmed">28053193</ArticleId></ArticleIdList></Reference><Reference><Citation>He Z, Si Y, Jiang T, Ma R, Zhang Y, Cao M, et al. . Phosphotidylserine Exposure and Neutrophil Extracellular Traps Enhance Procoagulant Activity in Patients With Inflammatory Bowel Disease. Thromb Haemost (2016) 115(4):738&#x2013;51. doi:&#xa0;10.1160/TH15-09-0710</Citation><ArticleIdList><ArticleId IdType="doi">10.1160/TH15-09-0710</ArticleId><ArticleId IdType="pubmed">26660948</ArticleId></ArticleIdList></Reference><Reference><Citation>Xie R, Gao C, Li W, Zhu J, Novakovic V, Wang J, et al. . Phagocytosis by Macrophages and Endothelial Cells Inhibits Procoagulant and Fibrinolytic Activity of Acute Promyelocytic Leukemia Cells. Blood (2012) 119(10):2325&#x2013;34. doi:&#xa0;10.1182/blood-2011-06-362186</Citation><ArticleIdList><ArticleId IdType="doi">10.1182/blood-2011-06-362186</ArticleId><ArticleId IdType="pubmed">22138513</ArticleId></ArticleIdList></Reference><Reference><Citation>Viecca M, Radovanovic D, Forleo GB, Santus P. Enhanced Platelet Inhibition Treatment Improves Hypoxemia in Patients With Severe COVID-19 and Hypercoagulability. A Case Control, Proof of Concept Study. Pharmacol Res (2020) 158:104950. doi:&#xa0;10.1016/j.phrs.2020.104950</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.phrs.2020.104950</ArticleId><ArticleId IdType="pmc">PMC7244436</ArticleId><ArticleId IdType="pubmed">32450344</ArticleId></ArticleIdList></Reference><Reference><Citation>Flaczyk A, Rosovsky RP, Reed CT, Bankhead-Kendall BK, Bittner EA, Chang MG. Comparison of Published Guidelines for Management of Coagulopathy and Thrombosis in Critically Ill Patients With COVID 19: Implications for Clinical Practice and Future Investigations. Crit Care (2020) 24(1):559. doi:&#xa0;10.1186/s13054-020-03273-y</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13054-020-03273-y</ArticleId><ArticleId IdType="pmc">PMC7492793</ArticleId><ArticleId IdType="pubmed">32938471</ArticleId></ArticleIdList></Reference><Reference><Citation>Billett HH, Reyes-Gil M, Szymanski J, Ikemura K, Stahl LR, Lo Y, et al. . Anticoagulation in COVID-19: Effect of Enoxaparin, Heparin, and Apixaban on Mortality. Thromb Haemost (2020) 120(12):1691&#x2013;9. doi:&#xa0;10.1055/s-0040-1720978</Citation><ArticleIdList><ArticleId IdType="doi">10.1055/s-0040-1720978</ArticleId><ArticleId IdType="pmc">PMC7869055</ArticleId><ArticleId IdType="pubmed">33186991</ArticleId></ArticleIdList></Reference><Reference><Citation>Short SAP, Gupta S, Brenner SK, Hayek SS, Srivastava A, Shaefi S, et al. . D-Dimer and Death in Critically Ill Patients With Coronavirus Disease 2019. Crit Care Med (2021) 49(5):e500&#x2013;11. doi:&#xa0;10.1097/CCM.0000000000004917</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/CCM.0000000000004917</ArticleId><ArticleId IdType="pmc">PMC8275993</ArticleId><ArticleId IdType="pubmed">33591017</ArticleId></ArticleIdList></Reference><Reference><Citation>Kruse JM, Magomedov A, Kurreck A, M&#xfc;nch FH, Koerner R, Kamhieh-Milz J, et al. . Thromboembolic Complications in Critically Ill COVID-19 Patients Are Associated With Impaired Fibrinolysis. Crit Care (2020) 24(1):676. doi:&#xa0;10.1186/s13054-020-03401-8</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13054-020-03401-8</ArticleId><ArticleId IdType="pmc">PMC7719734</ArticleId><ArticleId IdType="pubmed">33287877</ArticleId></ArticleIdList></Reference><Reference><Citation>Meizoso JP, Moore HB, Moore EE. Fibrinolysis Shutdown in COVID-19: Clinical Manifestations, Molecular Mechanisms, and Therapeutic Implications. J Am Coll Surg (2021) 232(6):995&#x2013;1003. doi:&#xa0;10.1016/j.jamcollsurg.2021.02.019</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jamcollsurg.2021.02.019</ArticleId><ArticleId IdType="pmc">PMC7982779</ArticleId><ArticleId IdType="pubmed">33766727</ArticleId></ArticleIdList></Reference><Reference><Citation>Bachler M, B&#xf6;sch J, St&#xfc;rzel DP, Hell T, Giebl A, Str&#xf6;hle M, et al. . Impaired Fibrinolysis in Critically Ill COVID-19 Patients. Br J Anaesth (2021) 126(3):590&#x2013;8. doi:&#xa0;10.1016/j.bja.2020.12.010</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bja.2020.12.010</ArticleId><ArticleId IdType="pmc">PMC7833514</ArticleId><ArticleId IdType="pubmed">33422287</ArticleId></ArticleIdList></Reference><Reference><Citation>Nougier C, Benoit R, Simon M, Desmurs-Clavel H, Marcotte G, Argaud L, et al. . Hypofibrinolytic State and High Thrombin Generation May Play a Major Role in SARS-CoV2 Associated Thrombosis. J Thromb Haemost (2020) 18(9):2215&#x2013;9. doi:&#xa0;10.1111/jth.15016</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/jth.15016</ArticleId><ArticleId IdType="pmc">PMC7405476</ArticleId><ArticleId IdType="pubmed">32668058</ArticleId></ArticleIdList></Reference><Reference><Citation>Thachil J, Tang N, Gando S, Falanga A, Cattaneo M, Levi M, et al. . ISTH Interim Guidance on Recognition and Management of Coagulopathy in COVID-19. J Thromb Haemost (2020) 18(5):1023&#x2013;6. doi:&#xa0;10.1111/jth.14810</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/jth.14810</ArticleId><ArticleId IdType="pmc">PMC9906133</ArticleId><ArticleId IdType="pubmed">32338827</ArticleId></ArticleIdList></Reference><Reference><Citation>Moores LK, Tritschler T, Brosnahan S, Carrier M, Collen JF, Doerschug K, et al. . Prevention, Diagnosis, and Treatment of VTE in Patients With Coronavirus Disease 2019: CHEST Guideline and Expert Panel Report. Chest (2020) 158(3):1143&#x2013;63. doi:&#xa0;10.1016/j.chest.2020.05.559</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.chest.2020.05.559</ArticleId><ArticleId IdType="pmc">PMC7265858</ArticleId><ArticleId IdType="pubmed">32502594</ArticleId></ArticleIdList></Reference><Reference><Citation>Cuker A, Tseng EK, Nieuwlaat R, Angchaisuksiri P, Blair C, Dane K, et al. . American Society of Hematology 2021 Guidelines on the Use of Anticoagulation for Thromboprophylaxis in Patients With COVID-19. Blood Adv (2021) 5(3):872&#x2013;88. doi:&#xa0;10.1182/bloodadvances.2020003763</Citation><ArticleIdList><ArticleId IdType="doi">10.1182/bloodadvances.2020003763</ArticleId><ArticleId IdType="pmc">PMC7869684</ArticleId><ArticleId IdType="pubmed">33560401</ArticleId></ArticleIdList></Reference><Reference><Citation>Spyropoulos AC, Levy JH, Ageno W, Connors JM, Hunt BJ, Iba T, et al. . Scientific and Standardization Committee Communication: Clinical Guidance on the Diagnosis, Prevention, and Treatment of Venous Thromboembolism in Hospitalized Patients With COVID-19. J Thromb Haemost (2020) 18(8):1859&#x2013;65. doi:&#xa0;10.1111/jth.14929</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/jth.14929</ArticleId><ArticleId IdType="pmc">PMC7283841</ArticleId><ArticleId IdType="pubmed">32459046</ArticleId></ArticleIdList></Reference><Reference><Citation>Gerotziafas GT, Catalano M, Colgan MP, Pecsvarady Z, Wautrecht JC, Fazeli B, et al. . Guidance for the Management of Patients With Vascular Disease or Cardiovascular Risk Factors and COVID-19: Position Paper From VAS-European Independent Foundation in Angiology/Vascular Medicine. Thromb Haemost (2020) 120(12):1597&#x2013;628. doi:&#xa0;10.1055/s-0040-1715798</Citation><ArticleIdList><ArticleId IdType="doi">10.1055/s-0040-1715798</ArticleId><ArticleId IdType="pmc">PMC7869052</ArticleId><ArticleId IdType="pubmed">32920811</ArticleId></ArticleIdList></Reference><Reference><Citation>Buijsers B, Yanginlar C, Maciej-Hulme ML, de Mast Q, van der Vlag J. Beneficial Non-Anticoagulant Mechanisms Underlying Heparin Treatment of COVID-19 Patients. EBioMedicine (2020) 59:102969. doi:&#xa0;10.1016/j.ebiom.2020.102969</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ebiom.2020.102969</ArticleId><ArticleId IdType="pmc">PMC7445140</ArticleId><ArticleId IdType="pubmed">32853989</ArticleId></ArticleIdList></Reference><Reference><Citation>Tacquard C, Mansour A, Godon A, Godet J, Poissy J, Garrigue D, et al. . Impact of High-Dose Prophylactic Anticoagulation in Critically Ill Patients With COVID-19 Pneumonia. Chest (2021) 159(6):2417&#x2013;27. doi:&#xa0;10.1016/j.chest.2021.01.017</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.chest.2021.01.017</ArticleId><ArticleId IdType="pmc">PMC7832130</ArticleId><ArticleId IdType="pubmed">33465342</ArticleId></ArticleIdList></Reference><Reference><Citation>Paranjpe I, Fuster V, Lala A, Russak AJ, Glicksberg BS, Levin MA, et al. . Association of Treatment Dose Anticoagulation With In-Hospital Survival Among Hospitalized Patients With COVID-19. J Am Coll Cardiol (2020) 76(1):122&#x2013;4. doi:&#xa0;10.1016/j.jacc.2020.05.001</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jacc.2020.05.001</ArticleId><ArticleId IdType="pmc">PMC7202841</ArticleId><ArticleId IdType="pubmed">32387623</ArticleId></ArticleIdList></Reference><Reference><Citation>Donato AA. In Non-Critically Ill Patients With COVID-19, Therapeutic Anticoagulation Improved Survival to Discharge Without Organ Support. Ann Intern Med (2021) 174(12):JC134. doi:&#xa0;10.7326/ACPJ202112210-134</Citation><ArticleIdList><ArticleId IdType="doi">10.7326/ACPJ202112210-134</ArticleId><ArticleId IdType="pubmed">34871053</ArticleId></ArticleIdList></Reference><Reference><Citation>Jonmarker S, Hollenberg J, Dahlberg M, Stackelberg O, Litorell J, Everhov &#xc5;H, et al. . Dosing of Thromboprophylaxis and Mortality in Critically Ill COVID-19 Patients. Crit Care (2020) 24(1):653. doi:&#xa0;10.1186/s13054-020-03375-7</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13054-020-03375-7</ArticleId><ArticleId IdType="pmc">PMC7680989</ArticleId><ArticleId IdType="pubmed">33225952</ArticleId></ArticleIdList></Reference><Reference><Citation>Al-Samkari H, Karp Leaf RS, Dzik WH, Carlson JCT, Fogerty AE, Waheed A, et al. . COVID-19 and Coagulation: Bleeding and Thrombotic Manifestations of SARS-CoV-2 Infection. Blood (2020) 136(4):489&#x2013;500. doi:&#xa0;10.1182/blood.2020006520</Citation><ArticleIdList><ArticleId IdType="doi">10.1182/blood.2020006520</ArticleId><ArticleId IdType="pmc">PMC7378457</ArticleId><ArticleId IdType="pubmed">32492712</ArticleId></ArticleIdList></Reference><Reference><Citation>Nadkarni GN, Lala A, Bagiella E, Chang HL, Moreno PR, Pujadas E, et al. . Anticoagulation, Bleeding, Mortality, and Pathology in Hospitalized Patients With COVID-19. J Am Coll Cardiol (2020) 76(16):1815&#x2013;26. doi:&#xa0;10.1016/j.jacc.2020.08.041</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jacc.2020.08.041</ArticleId><ArticleId IdType="pmc">PMC7449655</ArticleId><ArticleId IdType="pubmed">32860872</ArticleId></ArticleIdList></Reference><Reference><Citation>Connors JM, Levy JH. COVID-19 and Its Implications for Thrombosis and Anticoagulation. Blood (2020) 135(23):2033&#x2013;40. doi:&#xa0;10.1182/blood.2020006000</Citation><ArticleIdList><ArticleId IdType="doi">10.1182/blood.2020006000</ArticleId><ArticleId IdType="pmc">PMC7273827</ArticleId><ArticleId IdType="pubmed">32339221</ArticleId></ArticleIdList></Reference><Reference><Citation>Pavoni V, Gianesello L, Pazzi M, Stera C, Meconi T, Frigieri FC. Venous Thromboembolism and Bleeding in Critically Ill COVID-19 Patients Treated With Higher Than Standard Low Molecular Weight Heparin Doses and Aspirin: A Call to Action. Thromb Res (2020) 196:313&#x2013;7. doi:&#xa0;10.1016/j.thromres.2020.09.013</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.thromres.2020.09.013</ArticleId><ArticleId IdType="pmc">PMC7487146</ArticleId><ArticleId IdType="pubmed">32977129</ArticleId></ArticleIdList></Reference><Reference><Citation>Lopes RD, de Barros E Silva PGM, Furtado RHM, Macedo AVS, Bronhara B, Damiani LP, et al. . Therapeutic Versus Prophylactic Anticoagulation for Patients Admitted to Hospital With COVID-19 and Elevated D-Dimer Concentration (ACTION): An Open-Label, Multicentre, Randomised, Controlled Trial. Lancet (2021) 397(10291):2253&#x2013;63. doi:&#xa0;10.1016/S0140-6736(21)01203-4</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(21)01203-4</ArticleId><ArticleId IdType="pmc">PMC8177770</ArticleId><ArticleId IdType="pubmed">34097856</ArticleId></ArticleIdList></Reference><Reference><Citation>Kolanko E, Senderek T, Prokop-Staszecka A, Kruk A, Broniatowska E, Konieczy&#x144;ska M, et al. . Thromboprophylaxis in Hospitalized COVID-19 Patients: The Efficacy and Safety of the Approved Hospital Protocol. Pol Arch Intern Med (2021) 131(10):16102. doi:&#xa0;10.20452/pamw.16102</Citation><ArticleIdList><ArticleId IdType="doi">10.20452/pamw.16102</ArticleId><ArticleId IdType="pubmed">34605232</ArticleId></ArticleIdList></Reference><Reference><Citation>Kabir AA. Anticoagulation Is the Answer in Treating Noncritical COVID-19 Patients. Open Med (Wars) (2021) 16(1):1486&#x2013;92. doi:&#xa0;10.1515/med-2021-0354</Citation><ArticleIdList><ArticleId IdType="doi">10.1515/med-2021-0354</ArticleId><ArticleId IdType="pmc">PMC8494147</ArticleId><ArticleId IdType="pubmed">34703901</ArticleId></ArticleIdList></Reference><Reference><Citation>Chocron R, Galand V, Cellier J, Gendron N, Pommier T, Bory O, et al. . Critical COVID-19 France Investigators. Anticoagulation Before Hospitalization Is a Potential Protective Factor for COVID-19: Insight From a French Multicenter Cohort Study. J Am Heart Assoc (2021) 10(8):e018624. doi:&#xa0;10.1161/JAHA.120.018624</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/JAHA.120.018624</ArticleId><ArticleId IdType="pmc">PMC8174166</ArticleId><ArticleId IdType="pubmed">33550816</ArticleId></ArticleIdList></Reference><Reference><Citation>ATTACC Investigators. ACTIV-4a Investigators. REMAP-CAP Investigators. Lawler PR, Goligher EC, Berger JS, et al. . Therapeutic Anticoagulation With Heparin in Noncritically Ill Patients With COVID-19. N Engl J Med (2021) 385(9):790&#x2013;802. doi:&#xa0;10.1056/NEJMoa2105911</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMoa2105911</ArticleId><ArticleId IdType="pmc">PMC8362594</ArticleId><ArticleId IdType="pubmed">34351721</ArticleId></ArticleIdList></Reference><Reference><Citation>Rentsch CT, Beckman JA, Tomlinson L, Gellad WF, Alcorn C, Kidwai-Khan F, et al. . Early Initiation of Prophylactic Anticoagulation for Prevention of Coronavirus Disease 2019 Mortality in Patients Admitted to Hospital in the United States: Cohort Study. BMJ (2021) 372:n311. doi:&#xa0;10.1136/bmj.n311</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmj.n311</ArticleId><ArticleId IdType="pmc">PMC7876672</ArticleId><ArticleId IdType="pubmed">33574135</ArticleId></ArticleIdList></Reference><Reference><Citation>Cuker A, Tseng EK, Nieuwlaat R, Angchaisuksiri P, Blair C, Dane K, et al. . American Society of Hematology Living Guidelines on the Use of Anticoagulation for Thromboprophylaxis in Patients With COVID-19: July 2021 Update on Postdischarge Thromboprophylaxis. Blood Adv (2022) 6(2):664&#x2013;71. doi:&#xa0;10.1182/bloodadvances.2021005945</Citation><ArticleIdList><ArticleId IdType="doi">10.1182/bloodadvances.2021005945</ArticleId><ArticleId IdType="pmc">PMC8566097</ArticleId><ArticleId IdType="pubmed">34727173</ArticleId></ArticleIdList></Reference><Reference><Citation>Kanthi Y, Knight JS, Zuo Y, Pinsky DJ. New (Re)Purpose for an Old Drug: Purinergic Modulation May Extinguish the COVID-19 Thromboinflammatory Firestorm. JCI Insight (2020) 5(14):e140971. doi:&#xa0;10.1172/jci.insight.140971</Citation><ArticleIdList><ArticleId IdType="doi">10.1172/jci.insight.140971</ArticleId><ArticleId IdType="pmc">PMC7453890</ArticleId><ArticleId IdType="pubmed">32530438</ArticleId></ArticleIdList></Reference><Reference><Citation>Sriram K, Insel PA. Inflammation and Thrombosis in COVID-19 Pathophysiology: Proteinase-Activated and Purinergic Receptors As Drivers and Candidate Therapeutic Targets. Physiol Rev (2021) 101(2):545&#x2013;67. doi:&#xa0;10.1152/physrev.00035.2020</Citation><ArticleIdList><ArticleId IdType="doi">10.1152/physrev.00035.2020</ArticleId><ArticleId IdType="pmc">PMC8238137</ArticleId><ArticleId IdType="pubmed">33124941</ArticleId></ArticleIdList></Reference><Reference><Citation>Bianconi V, Violi F, Fallarino F, Pignatelli P, Sahebkar A, Pirro M. Is Acetylsalicylic Acid a Safe and Potentially Useful Choice for Adult Patients With COVID-19? Drugs (2020) 80(14):1383&#x2013;96. doi:&#xa0;10.1007/s40265-020-01365-1</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s40265-020-01365-1</ArticleId><ArticleId IdType="pmc">PMC7376326</ArticleId><ArticleId IdType="pubmed">32705604</ArticleId></ArticleIdList></Reference><Reference><Citation>Meizlish ML, Goshua G, Liu Y, Fine R, Amin K, Chang E, et al. . Intermediate-Dose Anticoagulation, Aspirin, and In-Hospital Mortality in COVID-19: A Propensity Score-Matched Analysis. Am J Hematol (2021) 96(4):471&#x2013;9. doi:&#xa0;10.1002/ajh.26102</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/ajh.26102</ArticleId><ArticleId IdType="pmc">PMC8013588</ArticleId><ArticleId IdType="pubmed">33476420</ArticleId></ArticleIdList></Reference><Reference><Citation>Chow JH, Khanna AK, Kethireddy S, Yamane D, Levine A, Jackson AM, et al. . Aspirin Use Is Associated With Decreased Mechanical Ventilation, Intensive Care Unit Admission, and In-Hospital Mortality in Hospitalized Patients With Coronavirus Disease 2019. Anesth Analg (2021) 132(4):930&#x2013;41. doi:&#xa0;10.1213/ANE.0000000000005292</Citation><ArticleIdList><ArticleId IdType="doi">10.1213/ANE.0000000000005292</ArticleId><ArticleId IdType="pubmed">33093359</ArticleId></ArticleIdList></Reference><Reference><Citation>Santoro F, Nu&#xf1;ez-Gil IJ, Vitale E, Viana-Llamas MC, Reche-Martinez B, Romero-Pareja R, et al. . Antiplatelet Therapy and Outcome in COVID-19: The Health Outcome Predictive Evaluation Registry. Heart (2022) 108(2):130&#x2013;6. doi:&#xa0;10.1136/heartjnl-2021-319552</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/heartjnl-2021-319552</ArticleId><ArticleId IdType="pmc">PMC8494537</ArticleId><ArticleId IdType="pubmed">34611045</ArticleId></ArticleIdList></Reference><Reference><Citation>Kor DJ, Carter RE, Park PK, Festic E, Banner-Goodspeed VM, Hinds R, et al. . Effect of Aspirin on Development of ARDS in At-Risk Patients Presenting to the Emergency Department: The LIPS-A Randomized Clinical Trial. JAMA (2016) 315(22):2406&#x2013;14. doi:&#xa0;10.1001/jama.2016.6330</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jama.2016.6330</ArticleId><ArticleId IdType="pmc">PMC5450939</ArticleId><ArticleId IdType="pubmed">27179988</ArticleId></ArticleIdList></Reference><Reference><Citation>Hou J, Fu Y, Zhou J, Li W, Xie R, Cao F, et al. . Lactadherin Functions As A Probe for Phosphatidylserine Exposure and As An Anticoagulant in the Study of Stored Platelets. Vox Sang (2011) 100(2):187&#x2013;95. doi:&#xa0;10.1111/j.1423-0410.2010.01375.x</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1423-0410.2010.01375.x</ArticleId><ArticleId IdType="pubmed">20738837</ArticleId></ArticleIdList></Reference><Reference><Citation>Dasgupta SK, Guchhait P, Thiagarajan P. Lactadherin Binding and Phosphatidylserine Expression on Cell Surface-Comparison With Annexin A5. Transl Res (2006) 148(1):19&#x2013;25. doi:&#xa0;10.1016/j.lab.2006.03.006</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.lab.2006.03.006</ArticleId><ArticleId IdType="pubmed">16887494</ArticleId></ArticleIdList></Reference><Reference><Citation>Shi J, Gilbert GE. Lactadherin Inhibits Enzyme Complexes of Blood Coagulation by Competing for Phospholipid-Binding Sites. Blood (2003) 101(7):2628&#x2013;36. doi:&#xa0;10.1182/blood-2002-07-1951</Citation><ArticleIdList><ArticleId IdType="doi">10.1182/blood-2002-07-1951</ArticleId><ArticleId IdType="pubmed">12517809</ArticleId></ArticleIdList></Reference><Reference><Citation>Dasgupta SK, Abdel-Monem H, Niravath P, Le A, Bellera RV, Langlois K, et al. . Lactadherin and Clearance of Platelet-Derived Microvesicles. Blood (2009) 113(6):1332&#x2013;9. doi:&#xa0;10.1182/blood-2008-07-167148</Citation><ArticleIdList><ArticleId IdType="doi">10.1182/blood-2008-07-167148</ArticleId><ArticleId IdType="pmc">PMC2637196</ArticleId><ArticleId IdType="pubmed">19023116</ArticleId></ArticleIdList></Reference><Reference><Citation>Kami&#x144;ska A, Enguita FJ, St&#x119;pie&#x144; E&#x141;. Lactadherin: An Unappreciated Haemostasis Regulator and Potential Therapeutic Agent. Vascul Pharmacol (2018) 101:21&#x2013;8. doi:&#xa0;10.1016/j.vph.2017.11.006</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.vph.2017.11.006</ArticleId><ArticleId IdType="pubmed">29169950</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>